An Opportunity for Medical Advancement: ONY Biotech’s Investigator-Initiated Research Program

Feb 23, 2024

At ONY Biotech, innovation is not just a buzzword; it’s a commitment woven into every breath we take. We are excited to announce our Investigator-Initiated Research program, designed to foster groundbreaking research initiatives that push the boundaries of medical and scientific knowledge in respiratory care and beyond.

Our program serves as a catalyst for researchers worldwide, inviting them to explore new frontiers in medical interventions and therapeutic advancements. Whether you’re investigating the administration methods of our flagship therapy, Infasurf (calfactant), or exploring novel delivery mechanisms for respiratory treatments,  we’re here to support your journey.

Areas of Interest

The Investigator-Initiated Research program focuses on several key areas related to the administration and study of Infasurf (calfactant). Researchers are encouraged to explore innovative approaches, including thin catheter methods (LISA), laryngeal or supraglottic airway devices (SALSA), aerosolized/nebulized dose forms, and more.

How to Get Involved

If you’re passionate about advancing medical science and have a research idea aligned with our program’s objectives, we invite you to connect with us at [email protected].

For more detailed information about our Investigator-Initiated Research Program, including project types eligible for support, please review the program details on our research page.

At ONY Biotech, we believe that the pursuit of knowledge is a collaborative endeavor. Join us in our mission to innovate with every breath and make a lasting impact on patients’ lives worldwide.

Infasurf® is FDA-approved for Intratracheal administration only. For full prescribing information, please visit: https://infasurf.com/prescribing-information/